94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1535504
This article is part of the Research Topic Current Trends and Future Prospects in the Use of Immunotherapy in Ovarian Cancer View all 4 articles
Exploring the mechanism of action of succinic acid in ovarian cancer via singlecell sequencing of the tumour immune microenvironment
Provisionally accepted- 1 Liaoning Cancer Hospital, China Medical University, Shenyang, China
- 2 Dalian University of Technology, Dalian, Liaoning Province, China
Background: The main treatments for ovarian cancer are surgery, chemotherapy, radiotherapy, and targeted therapy. Targeted therapy is a new treatment method that has emerged in recent years and relies on specific molecular targets to treat cancer. Succinic acid is a key intermediate product in the tricarboxylic acid cycle. Research has shown that succinic acid has antioxidant properties and can alleviate oxidative stress in cells and tissues. These findings indicate the potential application of succinic acid in antioxidant therapy and the prevention of oxidative damage. This study explored the potential targets and therapeutic mechanisms of succinic acid in ovarian cancer. Methods: Using bioinformatics and single-cell sequencing technology, the hub genes related to succinic acid and ovarian cancer and the frequency and gene expression patterns of different cell types in ovarian cancer patients and normal individuals were analysed.The frequency of immune cells, including B cells, CD4 + cells, CD8 + cells, macrophages, and plasma cells, was significantly increased in ovarian cancer patients, and the frequency of other cell types, such as endothelial cells, NK cells, and pericytes/SMCs, was decreased. Further research revealed three key hub genes: SPP1, SLPI, and CD9. The expression patterns of these genes in ovarian cancer were closely related to different cell types. SPP1 was expressed mainly in macrophages, SLPI was expressed in epithelial cells, and CD9 was expressed in pericytes/SMCs and epithelial cells. SPP1, SLPI, and CD9 and their mechanisms of action may be potential targets for the treatment of ovarian cancer with succinic acid. Conclusions: This study investigated the potential therapeutic targets and mechanisms of succinic acid in ovarian cancer and the differences in immune cell infiltration and gene expression patterns, providing important insights for future tumour immunotherapy research.
Keywords: Succinic Acid, ovarian cancer, Immune Cell Infiltration, single-cell RNA sequencing, SPP1
Received: 27 Nov 2024; Accepted: 27 Feb 2025.
Copyright: © 2025 Zhao, Guo, Zhao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jiao Zhao, Liaoning Cancer Hospital, China Medical University, Shenyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.